Meningitis Response Expands to New Drugs; Learn More on a CDC Call Today

October 16, 2012

As its investigation continues, the US Food and Drug Administration (FDA) is now recommending that all patients who received any injectable drugs purchased from or produced by New England Compounding Center (NECC) after May 21, 2012, including ophthalmic drugs that are injectable or used in conjunction with eye surgery and cardioplegic solutions, be notified of the potential risk of infection. Patients should also be instructed to immediately contact their health care provider if they experience any symptoms of meningitis.

At this time, no cases of infection have been reported in connection with any NECC-produced ophthalmic drug. However, the FDA believes that this class of products could potentially present similar risks of infection. At this time, the FDA is not urging patient follow-up for lower-risk NECC products, such as topicals (lotions, creams or eyedrops not used in conjunction with surgery) and suppositories.

The Centers for Disease Control and Prevention (CDC) and FDA had previously issued guidance that all health care professionals discontinue the use of any product produced by NECC—the supplier of the epidural steroid associated with the cases of fungal meningitis.

Click here for a complete list of recalled products.

Health care providers are also being asked to report any suspected adverse events following use of these products to FDA’s MedWatch program at 1.800.332.1088 or

Health care professionals may dial FDA’s Drug Information Line at 855.543.3784 and press * to get the most recent information regarding the meningitis recall and speak directly to a pharmacist.

Join the CDC Call Today

The CDC conference call today, beginning at 2 pm ET, will give an update on the investigation. During the call, subject matter experts will provide updates to the current epidemiology of the outbreak, describe clinical presentation and features of fungal meningitis and review the CDC’s recommended treatment guidance.

To join the call, use the dial-in number 888.790.6180 and the passcode “1281914.” If you have questions or trouble accessing this call, please email

Click here for more CDC resources about the outbreak.